Search Results - "Biggs, Judith A"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8+ T Lymphocytes into Effector CTL by Lyman, Michael A, Aung, Sandra, Biggs, Judith A, Sherman, Linda A

    Published in The Journal of immunology (1950) (01-06-2004)
    “…In this report, we address whether a growing tumor provides sufficient inflammatory signals to promote activation, clonal expansion, and acquisition of…”
    Get full text
    Journal Article
  2. 2

    The Fate of Low Affinity Tumor-Specific CD8+ T Cells in Tumor-Bearing Mice by Lyman, Michael A, Nugent, C. Thomas, Marquardt, Kristi L, Biggs, Judith A, Pamer, Eric G, Sherman, Linda A

    Published in The Journal of immunology (1950) (01-03-2005)
    “…A major challenge in tumor immunology is how best to activate the relatively low avidity self-specific and tumor-specific T cells that are available in the…”
    Get full text
    Journal Article
  3. 3

    Altered functional and biochemical response by CD8+ T cells that remain after tolerance by Murtaza, Anwar, Nugent, C. Thomas, Tailor, Pankaj, Asensio, Valerie C., Biggs, Judith A., Campbell, Iain L., Sherman, Linda A.

    Published in International immunology (01-08-2001)
    “…To further define the molecular basis of tolerance to a peripherally expressed antigen we have correlated differences in functional capacity with biochemical…”
    Get full text
    Journal Article
  4. 4

    Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas by Nugent, C. Thomas, Morgan, David J, Biggs, Judith A, Ko, Alice, Pilip, Ingrid M, Pamer, Eric G, Sherman, Linda A

    Published in The Journal of immunology (1950) (01-01-2000)
    “…As a result of expression of the influenza hemagglutinin (HA) in the pancreatic islets, the repertoire of HA-specific CD8+ T lymphocytes in InsHA transgenic…”
    Get full text
    Journal Article
  5. 5

    Defective CD8+ T Cell Peripheral Tolerance in Nonobese Diabetic Mice by Kreuwel, Huub T. C, Biggs, Judith A, Pilip, Ingrid M, Pamer, Eric G, Lo, David, Sherman, Linda A

    Published in The Journal of immunology (1950) (15-07-2001)
    “…Nonobese diabetic (NOD) mice develop spontaneous autoimmune diabetes that involves participation of both CD4+ and CD8+ T cells. Previous studies have…”
    Get full text
    Journal Article
  6. 6

    Alloantibodies can Discriminate Class I Major Histocompatibility Complex Molecules Associated with Various Endogenous Peptides by Sherman, Linda A., Chattopadhyay, Suschmitta, Biggs, Judith A., Dick, Robert F., Bluestone, Jeffrey A.

    “…Molecules encoded by a single major histocompatibility complex class I gene can associate with any one of a large number of peptide ligands. T-cell receptors…”
    Get full text
    Journal Article
  7. 7

    Using gamma‐cytokine complexes to improve antigen specific CD8 T cell responses in tumor‐bearing mice by Verdeil, Gregory, Marquardt, Kristi L, Biggs, Judith A, Surh, Charles D, Sherman, Linda A

    Published in The FASEB journal (01-03-2008)
    “…Abstract only In the absence of inflammatory signals, the exposure of T cells to tumor antigen in the periphery results in tolerance. Remaining tumor specific…”
    Get full text
    Journal Article
  8. 8

    A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8 super(+) T Lymphocytes into Effector CTL by Lyman, Michael A, Aung, Sandra, Biggs, Judith A, Sherman, Linda A

    Published in The Journal of immunology (1950) (01-06-2004)
    “…In this report, we address whether a growing tumor provides sufficient inflammatory signals to promote activation, clonal expansion, and acquisition of…”
    Get full text
    Journal Article
  9. 9

    The Fate of Low Affinity Tumor-Specific CD8 super(+) T Cells in Tumor-Bearing Mice by Lyman, Michael A, Nugent, CThomas, Marquardt, Kristi L, Biggs, Judith A, Pamer, Eric G, Sherman, Linda A

    Published in The Journal of immunology (1950) (01-03-2005)
    “…A major challenge in tumor immunology is how best to activate the relatively low avidity self-specific and tumor-specific T cells that are available in the…”
    Get full text
    Journal Article
  10. 10

    Extracellular processing of peptide antigens that bind class I major histocompatibility molecules by SHERMAN, L. A, BURKE, T. A, BIGGS, J. A

    Published in The Journal of experimental medicine (01-05-1992)
    “…One problem associated with the use of synthetic peptides as antigens in vivo is their susceptibility to inactivation by proteolytic degradation. A situation…”
    Get full text
    Journal Article